56966-48-4 Usage
Uses
Used in Pharmaceutical Industry:
5-Chloro-2-(2-chlorophenoxy)aniline is used as an intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be a key component in the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 5-Chloro-2-(2-chlorophenoxy)aniline is utilized as a precursor in the production of certain pesticides and herbicides. Its chemical properties make it suitable for the creation of compounds that can effectively control pests and weeds in agricultural settings.
Used in Dye Industry:
5-Chloro-2-(2-chlorophenoxy)aniline is employed as a building block in the synthesis of various dyes. Its ability to form stable color compounds makes it a valuable component in the production of dyes used in textiles, plastics, and other industries.
Used in Research and Development:
This chemical compound is also used in research and development settings to explore its potential applications and properties. Scientists and researchers utilize 5-Chloro-2-(2-chlorophenoxy)aniline to study its reactivity, stability, and interactions with other chemicals, which can lead to the discovery of new applications and uses.
Check Digit Verification of cas no
The CAS Registry Mumber 56966-48-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,9,6 and 6 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 56966-48:
(7*5)+(6*6)+(5*9)+(4*6)+(3*6)+(2*4)+(1*8)=174
174 % 10 = 4
So 56966-48-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H9Cl2NO/c13-8-5-6-12(10(15)7-8)16-11-4-2-1-3-9(11)14/h1-7H,15H2
56966-48-4Relevant academic research and scientific papers
PYRIDINYL SULFONAMIDE MODULATORS OF CHEMOKINE RECEPTORS
-
Page/Page column 21-22, (2010/11/27)
The present invention relates to compounds of following formula (I) or pharmaceutically acceptable salts thereof; pharmaceutical compositions containing them, and their use in the treatment of disorders mediated by the CCR-2 receptor.
